1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Epiomic Epidemiology Series: Retinal Vein Occlusion Forecast in 8 Major Markets 2015-2025

Summary

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Retinal Vein Occlusion in 8 Major Markets

Retinal Vein Occlusion (RVO) is a common vascular disorder of the retina and one of the most common causes of vision loss worldwide. It is caused by the blockage of a portion of the venous circulation that drains the retina and can result in haemorrhage and fluid loss. This report provides the current prevalent population for RVO across 8 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report provides an overview of the types, occlusion locations and the prevalence of associated disorders of RVO. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of RVO have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for RVO include:

-Visual complications
-Blindness
-Cardiovascular diseases
-Diabetes mellitus
-Hypertension
-Glaucoma
-Dense Muscular haemorrhage

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy
-Able to quantify patient populations in global RVO’s market to target the development of future products, pricing strategies and launch plans.
-Gain further insight into the prevalence of the subdivided types of RVO and identify patient segments with high potential.
-Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
-Provide a level of understanding on the impact from specific co-morbid conditions on RVO’s prevalent population.
-Identify sub-populations within RVO which require treatment.
-Gain an understanding of the specific markets that have the largest number of RVO patients.

Table Of Contents

Epiomic Epidemiology Series: Retinal Vein Occlusion Forecast in 8 Major Markets 2015-2025
Retinal Vein Occlusion
Table of Contents
-List of Tables and Figures
-Overview
-Introduction
-Cause of the Disease
-Risk Factors and Prevention
-Diagnosis of the Disease
-Variation by Geography/Ethnicity
-Disease Prognosis andClinical Course
-Key Comorbid Conditions/Features Associated with the Disease
-Methodology for Quantification of Patient Numbers
-Top-Line RVO Prevalence
-Main Type of RVO
-Occlusion location of RVO
-Central RVO
o Co-morbidities within CRVO
-Branch RVO
o Co-morbidities within BRVO
-References
-Appendix

List of Tables and Figures
-Prevalence of RVO, total (000s)
-Prevalence of RVO, males (000s)
-Prevalence of RVO, females (000s)
-RVO by vein affected, total (000s)
-Main occlusion location for RVO, total (000s)
-Prevalence of CRVO by main aetiology, total (000s)
-Glaucoma by type within CRVO, total (000s)
-Prevalence of Diabetes in CRVO, total (000s)
-Prevalence of Hypertension in CRVO, total (000s)
-Prevalence of BRVO by main type, total (000s)
-Macular status at diagnosis of BRVO, total (000s)
-Glaucoma by type within BRVO, total (000s)
-Prevalence of Diabetes in BRVO, total (000s)
-Prevalence of Hypertension in BRVO, total (000s)
-Prevalence of Dense macular haemorrhage in BRVO, total (000s)
-USA Prevalence of RVO by 5-yr age cohort, males (000s)
-USA Prevalence of RVO by 5-yr age cohort, females (000s)
-France Prevalence of RVO by 5-yr age cohort, males (000s)
-France Prevalence of RVO by 5-yr age cohort, females (000s)
-Germany Prevalence of RVO by 5-yr age cohort, males (000s)
-Germany Prevalence of RVO by 5-yr age cohort, females (000s)
-Italy Prevalence of RVO by 5-yr age cohort, males (000s)
-Italy Prevalence of RVO by 5-yr age cohort, females (000s)
-Spain Prevalence of RVO by 5-yr age cohort, males (000s)
-Spain Prevalence of RVO by 5-yr age cohort, females (000s)
-United Kingdom Prevalence of RVO by 5-yr age cohort, males (000s)
-United Kingdom Prevalence of RVO by 5-yr age cohort, females (000s)
-Brazil Prevalence of RVO by 5-yr age cohort, males (000s)
-Brazil Prevalence of RVO by 5-yr age cohort, females (000s)
-Japan Prevalence of RVO by 5-yr age cohort, males (000s)
-Japan Prevalence of RVO by 5-yr age cohort, females (000s)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.